MediWound Ltd. Announces $30 Million Registered Direct Offering of Ordinary Shares Led by U.S. Mutual Fund
I'm PortAI, I can summarize articles.
MediWound Ltd. has announced a $30 million registered direct offering of 1,734,105 ordinary shares at $17.30 per share, led by a U.S.-based mutual fund. The proceeds will primarily support pre-commercial activities for EscharEx, enhance manufacturing capabilities, and cover general corporate purposes. H.C. Wainwright & Co. is the exclusive placement agent for this offering.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments